2. Academic Validation
  3. EP300 deficiency leads to chronic replication stress mediated by defective replication fork protection

EP300 deficiency leads to chronic replication stress mediated by defective replication fork protection

  • Nat Commun. 2025 Dec 7. doi: 10.1038/s41467-025-67171-z.
Angelica Barreto-Galvez # 1,  Mrunmai Niljikar # 1,  Julia Elizabeth Gagliardi 1,  Carolina Plasencia Guzman 1,  Ranran Zhang 1,  Vasudha Kumar 1,  Aastha Juwarwala 1,  Archana Pradeep 1,  Ankit Saxena 1,  Cristina Montagna 1 2,  Priya Mittal 3,  Jeannine Gerhardt 4,  Bing Xia 5,  Jian Cao 1 6,  Keisuke Kataoka 7,  Adam David Durbin 8,  Jun Qi 9,  B Hilda Ye 10,  Advaitha Madireddy 11 12
Affiliations

Affiliations

  • 1 Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
  • 2 Department of Genetics, Albert Einstein College of Medicine, Bronx, NY, USA.
  • 3 Center of Excellence in Neuro-Oncology Sciences (CENOS), St. Jude Children's Research Hospital, Memphis, TN, USA.
  • 4 Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, NY, USA.
  • 5 Department of Radiation Oncology, Rutgers University, New Brunswick, NJ, USA.
  • 6 Department of Medicine, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA.
  • 7 Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan.
  • 8 Department of Oncology, St. Jude Comprehensive Cancer Center, Memphis, TN, USA.
  • 9 Department of Cancer Biology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • 10 Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY, USA.
  • 11 Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. Advaitha.madireddy@rutgers.edu.
  • 12 Department of Pediatrics Hematology/Oncology, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA. Advaitha.madireddy@rutgers.edu.
  • # Contributed equally.
PMID: 41354653 DOI: 10.1038/s41467-025-67171-z
Abstract

Mutations in the global transcriptional activator EP300/KAT3B are being reported in aggressive malignancies. However, the mechanistic contribution of EP300 dysregulation to Cancer is currently unknown. While EP300 has been implicated in regulating cell cycle and DNA replication, the role of EP300 in maintaining replication fork integrity has not been studied. Here, using EP300-mutated adult T-cell leukemia/lymphoma cells and an EP300-selective degrader, we reveal that EP300 loss leads to pronounced dysregulations in DNA replication dynamics and persistent genomic instability. Aberrant DNA replication in EP300-mutated cells is characterized by elevated replication origin firing due to replisome pausing. EP300 deficiency results in a prominent defect in fork protection resulting in the accumulation of single-stranded DNA gaps. Importantly, we find that the loss of EP300 results in decreased expression of BRCA2 protein leading to sensitivity to treatments that are cytotoxic to BRCA-deficient cancers. Overall, we demonstrate that EP300-mutated cells recapitulate features of BRCA-deficient cancers.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z